Sidley Represents Sino Biopharmaceutical in its US$7 Billion Licensing Agreement With Boehringer Ingelheim
November 09, 2026
November 09, 2026
CHICAGO, Illinois, Nov. 9 [Category: BizLaw/Legal] -- Sidley Austin, a law firm, posted the following news release:
* * *
Sidley Represents Sino Biopharmaceutical in its US$7 Billion Licensing Agreement With Boehringer Ingelheim
*
Sidley represented Sino Biopharmaceutical Limited in an option and license agreement with Boehringer Ingelheim covering six preclinical oncology programs involving antibody-drug conjugates (ADCs) and T-cell engagers ( . . .
* * *
Sidley Represents Sino Biopharmaceutical in its US$7 Billion Licensing Agreement With Boehringer Ingelheim
*
Sidley represented Sino Biopharmaceutical Limited in an option and license agreement with Boehringer Ingelheim covering six preclinical oncology programs involving antibody-drug conjugates (ADCs) and T-cell engagers ( . . .
